Advanced AI solutions for early detection and screening of vision-threatening eye diseases, bringing expert-level diagnostics to primary care settings.
Early detection of diabetic retinopathy through advanced AI analysis of retinal images, preventing vision loss in diabetic patients.

Comprehensive optic nerve assessment for early glaucoma detection and monitoring of disease progression.

Our AI models achieve over 98% accuracy in detecting diabetic retinopathy and 96% accuracy in glaucoma screening, matching or exceeding expert-level performance.
Reduce diagnostic time from 30 minutes to under 2 minutes per patient, allowing healthcare providers to screen more patients with consistent quality.
Decrease diagnostic costs by up to 70% while maintaining high-quality screening, making eye care more accessible in underserved regions.
Identify vision-threatening conditions in early stages when interventions are most effective, preventing irreversible vision loss in 90% of cases.
Scale eye care services to remote and underserved areas without requiring specialist presence, reaching populations previously without access.
Provide evidence-based recommendations to enhance clinical decision-making and standardize care quality across diverse healthcare settings.
Integrate AI screening into primary care settings for routine eye health checks
Enable remote screening for patients in rural or underserved areas
Deploy for large-scale screening programs in communities or workplaces
Track disease progression and treatment effectiveness over time
Implement our AI-powered diagnostic tools to improve patient outcomes, increase efficiency, and expand access to quality eye care.